정밀의학 생명공학기업 마크로젠은 개개인이 타고난 유전적 특성을 정확히 알고 보다 건강한 삶을 준비할 수 있도록 돕는 초개인화 헬스케어 서비스를 제공합니다.
macrogen service
Combining top-tier global
genomic analysis expertise
withBig DataandAI
We are creating pathways to a healthier life
macrogen service
Driving continuous growth and leading
the paradigm shift in healthcare.
-
No.1
Market Share
in South Korea -
467
18K+ Customers
in 153 Countries -
Top1
Sequencing Capacity
300K+ Genome per Year -
82PB
Big Data Computing
Infrastructure -
560+
Number of Employees
-
406
SCI-level Articles
in Top-tier Journals
macrogen global network
We deliver timely, systematic services tailored to
meet your needs, wherever you are
Macrogen Gangnam HQ
Macrogen Genome Center
Macrogen Songdo Global Campus
Macrogen Sejong Campus
Macrogen Japan
Macrogen APAC
Macrogen Europe
Madrid Genome Center
Milano Genome Center
Paris Genome Center
Szczecin Genome Center
Basel Genome Center
Psomagen
Santiago Genome Center
macrogen news
News
-
Business
Macrogen Launches GenTok Service on Samsung Galaxy, Ushering in Korea’s First Era of Personalized, DNA-Based Healthcare
March 31, 2025 - Macrogen Inc. (CEO Changhoon Kim), a global leader in digital healthcare, announced the official launch of its GenTok platform integrated with Samsung Health. Following an official service agreement signed with Samsung Electronics in November last year, Macrogen has been preparing a healthcare service on genetic testing. Through this integration, users can now combine their daily health data—such as exercise, sleep, and body composition—with genetic insights from GenTok to receive a more personalized and optimized health guide.
-
Corporate
Macrogen Holds Completion Ceremony for ‘Sejong Campus,’ Launching as a Future-Oriented Integrated Genome Center
December 2, 2024 - Macrogen Inc. (CEO Changhoon Kim), a global leader in genomic analysis, announced that it held the completion ceremony for its new ‘Macrogen Sejong Campus’ on November 29 at Sejong Technovalley. The event was attended by over 70 key figures and stakeholders, including Sejong City Mayor Min-ho Choi and National Biobank Center Director Hae-young Jung.
-
Business
Macrogen Selected as Final Contractor for Korea's Largest Bio Big Data Project
December 9, 2024 -Macrogen, a global leader in genomic analysis, in partnership with DNA Link, Theragen Bio, and CG invites, has been selected as the final contractor forNational Integrated Bio Big Data Project, supported by the Ministry of Health and Welfare and the Korea Disease Control and Prevention Agency, and commissioned by the Korea Research Institute of Bioscience and Biotechnology.
